These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23185449)

  • 1. Molecular pathways involved in prostate carcinogenesis: insights from public microarray datasets.
    Baetke SC; Adriaens ME; Seigneuric R; Evelo CT; Eijssen LM
    PLoS One; 2012; 7(11):e49831. PubMed ID: 23185449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis reveals disease-associated genes and biomarkers for prostate cancer progression.
    Li Y; Vongsangnak W; Chen L; Shen B
    BMC Med Genomics; 2014; 7 Suppl 1(Suppl 1):S3. PubMed ID: 25080090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency.
    Yeh HY; Cheng SW; Lin YC; Yeh CY; Lin SF; Soo VW
    BMC Med Genomics; 2009 Dec; 2():70. PubMed ID: 20025723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.
    Gao L; Zhang LJ; Li SH; Wei LL; Luo B; He RQ; Xia S
    Pathol Res Pract; 2018 May; 214(5):732-749. PubMed ID: 29559248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying novel prostate cancer associated pathways based on integrative microarray data analysis.
    Wang Y; Chen J; Li Q; Wang H; Liu G; Jing Q; Shen B
    Comput Biol Chem; 2011 Jun; 35(3):151-8. PubMed ID: 21704261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.
    Gu P; Yang D; Zhu J; Zhang M; He X
    Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying molecular features for prostate cancer with Gleason 7 based on microarray gene expression profiles.
    Bălăcescu L; Bălăcescu O; Crişan N; Fetica B; Petruţ B; Bungărdean C; Rus M; Tudoran O; Meurice G; Irimie A; Dragoş N; Berindan-Neagoe I
    Rom J Morphol Embryol; 2011; 52(4):1195-202. PubMed ID: 22203922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and identification of key biomarkers in prostate cancer using bioinformatics.
    Li S; Hou J; Xu W
    Mol Med Rep; 2020 Jan; 21(1):311-319. PubMed ID: 31746380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker identification for prostate cancer and lymph node metastasis from microarray data and protein interaction network using gene prioritization method.
    Arias CR; Yeh HY; Soo VW
    ScientificWorldJournal; 2012; 2012():842727. PubMed ID: 22654636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor and microRNA regulation in androgen-dependent and -independent prostate cancer cells.
    Wang G; Wang Y; Feng W; Wang X; Yang JY; Zhao Y; Wang Y; Liu Y
    BMC Genomics; 2008 Sep; 9 Suppl 2(Suppl 2):S22. PubMed ID: 18831788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A stochastic model for identifying differential gene pair co-expression patterns in prostate cancer progression.
    Mo WJ; Fu XP; Han XT; Yang GY; Zhang JG; Guo FH; Huang Y; Mao YM; Li Y; Xie Y
    BMC Genomics; 2009 Jul; 10():340. PubMed ID: 19640296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of prostate cancer biomarkers by microarray gene expression profiling.
    Sørensen KD; Ørntoft TF
    Expert Rev Mol Diagn; 2010 Jan; 10(1):49-64. PubMed ID: 20014922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating biomedical knowledge to model pathways of prostate cancer progression.
    Morris DS; Tomlins SA; Rhodes DR; Mehra R; Shah RB; Chinnaiyan AM
    Cell Cycle; 2007 May; 6(10):1177-87. PubMed ID: 17495538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
    Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
    Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer biomarker discovery: the entropic hallmark.
    Berretta R; Moscato P
    PLoS One; 2010 Aug; 5(8):e12262. PubMed ID: 20805891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer.
    Rhodes DR; Barrette TR; Rubin MA; Ghosh D; Chinnaiyan AM
    Cancer Res; 2002 Aug; 62(15):4427-33. PubMed ID: 12154050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.
    Lapuk AV; Wu C; Wyatt AW; McPherson A; McConeghy BJ; Brahmbhatt S; Mo F; Zoubeidi A; Anderson S; Bell RH; Haegert A; Shukin R; Wang Y; Fazli L; Hurtado-Coll A; Jones EC; Hach F; Hormozdiari F; Hajirasouliha I; Boutros PC; Bristow RG; Zhao Y; Marra MA; Fanjul A; Maher CA; Chinnaiyan AM; Rubin MA; Beltran H; Sahinalp SC; Gleave ME; Volik SV; Collins CC
    J Pathol; 2012 Jul; 227(3):286-97. PubMed ID: 22553170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.